Inogen (INGN) Other financing activities (2013 - 2026)

Inogen's (INGN) quarterly Other financing activities came in at $373000.0 in Q1 2026, down 23.72% year-on-year from $489000.0 in Q1 2025, and down 22.61% on a QoQ basis from $482000.0 in Q3 2025.

Inogen (INGN) Other financing activities (2013 - 2026) Analysis & Trends

Inogen (INGN) has 14 years of Other financing activities data on file, last reported at $373000.0 in Q1 2026.

  • On a quarterly basis, Other financing activities fell 23.72% year-over-year to $373000.0 in Q1 2026; TTM through Mar 2026 was $855000.0, a 8.06% decrease from a year earlier, with the FY2025 full-year figure at $971000.0, up 19.73% from the prior year.
  • Other financing activities for Q1 2026 stood at $373000.0, down from $482000.0 in the prior quarter.
  • Over the last five years, Other financing activities for INGN reached as high as $1.7 million in Q3 2022 and fell as low as -$1.6 million in Q4 2022.
  • Historically, Other financing activities has averaged $299363.6 across 5 years, with a median of $384000.0 in 2023.
  • Across the five-year window, Other financing activities tumbled 99.25% in 2022 and soared 1224.14% in 2023, its largest moves.
  • Year by year, Other financing activities stood at -$1.6 million in 2022, then jumped by 143.11% to $710000.0 in 2023, then tumbled by 37.89% to $441000.0 in 2024, then climbed by 9.3% to $482000.0 in 2025, then declined by 22.61% to $373000.0 in 2026.
  • Per Business Quant data, the three most recent Other financing activities figures were $373000.0 in Q1 2026, $482000.0 in Q3 2025, and $489000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Inogen 172.68 Mn 62.51 Mn 37.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 373,000.00
Mar 31, 2026 373,000.00
Sep 30, 2025 482,000.00
Sep 30, 2025 482,000.00
Mar 31, 2025 489,000.00
Mar 31, 2025 489,000.00
Sep 30, 2024 441,000.00
Sep 30, 2024 441,000.00
Mar 31, 2024 370,000.00
Mar 31, 2024 370,000.00
Dec 31, 2023 710,000.00
Dec 31, 2023 710,000.00
Mar 31, 2023 384,000.00
Mar 31, 2023 384,000.00
Dec 31, 2022 -1.65 Mn
Dec 31, 2022 -1.65 Mn
Sep 30, 2022 1.66 Mn
Sep 30, 2022 1.66 Mn
Jun 30, 2022 6,000.00
Jun 30, 2022 6,000.00